What is lupus?

Penn Medicine’s rheumatologists apply a multidisciplinary approach to the diagnosis, management and treatment of patients with systemic lupus erythematosus. Patients with lupus are among the most diagnostically and therapeutically complicated patients and often require a highly specialized team approach for optimal management.

Systemic lupus erythematosus (SLE) is a complex autoimmune disease involving the production of autoantibodies and dysregulation of the immune system. Diagnosing SLE can be challenging because every patient may present with a unique set of symptoms ranging from a mild skin rash and joint pain to severe, life-threatening disease involving many organ systems.

SLE can adversely affect cardiac, pulmonary, gastrointestinal, hematologic, renal and neurologic function in a variety of ways that have the potential to be life-threatening. SLE has been closely linked to antiphospholipid antibody syndrome which carries the risk of stroke and miscarriage; premature osteoporosis and increased fractures; and early atherosclerosis and myocardial infarctions.

Patients with SLE can be afflicted with musculoskeletal symptoms as well as chronic pain syndromes like fibromyalgia. SLE is linked to psychosocial and psychiatric difficulties that can create treatment challenges for both patients and physicians. In addition, the toxicities of the immunosuppressive medications used to treat SLE add to the complexity of balancing the risks and benefits in therapeutic decision making

Diagnosis of lupus

Accurate diagnosis of SLE requires a detailed investigation of every symptom with lab and imaging evaluation, as well as appropriate referrals to additional subspecialists. Careful assessment of the potential disease manifestations and weighing the elements of the treatment approaches are essential to providing effective care to patients with SLE. Generally, this is overseen by the rheumatologist, but frequently involves expert input from Penn Medicine’s team of nephrologists, pulmonologists, dermatologists and other specialists.

Treatment at Penn Medicine

The physicians at Penn Medicine have developed a multidisciplinary approach to achieve this concept of comprehensive care. At the center of the program is a collaborative outpatient practice shared by the divisions of renal-electrolyte and hypertension and rheumatology. As a result, lupus patients with renal disease can schedule office visits with both their nephrologist and rheumatologist on the same day.

In addition to the close cooperation of Penn Medicine nephrologists and rheumatologists, the ability of the lupus program to address the needs for multidisciplinary care rests with an extensive network of providers, including:

  • Cognitive behavioral therapy
  • Gastroenterology
  • Hematology
  • Neurology
  • Ophthalmology
  • Pain management
  • Pain psychology
  • Physical therapy
  • Psychiatry
  • Pulmonary
  • Renal-electrolyte and hypertension

Penn Medicine is actively developing bridges to basic and translational research and participating in clinical therapeutic trials.

Related specialties

Patient stories

CNN anchor Kasie Hunt had brain surgery at Penn

Before starting her own daily news show, journalist Kasie Hunt came to Penn Medicine for a growing brain tumor that was causing painful headaches.

‘You won the lottery’: The very first CAR T cell patient

Bill Ludwig will forever be known as the first person successfully treated with a cellular therapy that kills cancer cells with his own immune system.

A community hospital is a destination for cancer care

At Lancaster General Health, receiving advanced treatments closer to home has changed the battle with cancer for patients across central Pennsylvania.

Finding triple-negative breast cancer at 33, she chose ‘Team Penn’

Shocked to learn she had stage III breast cancer, Kate Korson knew just where to go. She flew home to Penn Medicine, where a clinical trial saved her life.

In the face of skin cancer, proton made all the difference

A Lancaster man and father of two reveals how proton therapy helped him beat skin cancer and reclaim his life.

Patient puts national spotlight on cancer clinical trials

As Kate Korson recently shared on Good Morning America, both she and her mother participated in clinical trials at Abramson Cancer Center.

Life, gained: Walter Styer’s CAR T story

Walter Styer’s 11+ life-filled years after being the 10th participant in an early trial, are a testament to the impact of CAR T cell immunotherapy.

The road to recovery begins at home

Penn Medicine’s SNF at Home pilot program offers a seamless transition from the hospital to home with extra support to recover in familiar surroundings.

How home care connects real-life settings to patients’ healing

At-home care means helping people within their real environment, a personalized approach to care in the local community.

Faith, fate, and families

At the Basser Center for BRCA at Penn, a unique philanthropic investment is making rapid progress toward preventing and treating heritable cancer.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.